Mireia Oliván

7.6k total citations
42 papers, 1.2k citations indexed

About

Mireia Oliván is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Mireia Oliván has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Pulmonary and Respiratory Medicine and 12 papers in Physiology. Recurrent topics in Mireia Oliván's work include Prostate Cancer Treatment and Research (14 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Muscle Physiology and Disorders (7 papers). Mireia Oliván is often cited by papers focused on Prostate Cancer Treatment and Research (14 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Muscle Physiology and Disorders (7 papers). Mireia Oliván collaborates with scholars based in Spain, United States and United Kingdom. Mireia Oliván's co-authors include Francisco J. López‐Soriano, Sı́lvia Busquets, Josep M. Argilés, Maite Figueras, Juan Moróte, José Pinhata Otoch, Paulo Sérgio Martins de Alcântara, Marília Seelaender, Miguél L. Batista and Elisabet Ametller and has published in prestigious journals such as Genes & Development, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Mireia Oliván

42 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mireia Oliván Spain 18 640 480 256 191 170 42 1.2k
Dominick G. A. Burton United Kingdom 17 736 1.1× 719 1.5× 201 0.8× 139 0.7× 179 1.1× 21 1.7k
Reiko Matsui United States 23 822 1.3× 377 0.8× 116 0.5× 173 0.9× 84 0.5× 48 1.5k
Stefan K. Nilsson Sweden 21 554 0.9× 443 0.9× 178 0.7× 76 0.4× 90 0.5× 39 1.9k
Young‐Sil Yoon South Korea 12 733 1.1× 488 1.0× 161 0.6× 68 0.4× 95 0.6× 12 1.3k
Yi Pan Canada 18 591 0.9× 392 0.8× 139 0.5× 189 1.0× 98 0.6× 41 1.7k
Yunbiao Lu United States 14 660 1.0× 215 0.4× 172 0.7× 133 0.7× 172 1.0× 17 1.3k
Krista P. Terracina United States 13 536 0.8× 236 0.5× 119 0.5× 105 0.5× 289 1.7× 21 992
Gangarao Davuluri United States 20 541 0.8× 629 1.3× 94 0.4× 61 0.3× 82 0.5× 31 1.3k
Eric S. Muise United States 16 1.1k 1.7× 832 1.7× 164 0.6× 70 0.4× 229 1.3× 30 2.3k
Naijin Zhang China 22 730 1.1× 141 0.3× 223 0.9× 96 0.5× 177 1.0× 71 1.3k

Countries citing papers authored by Mireia Oliván

Since Specialization
Citations

This map shows the geographic impact of Mireia Oliván's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mireia Oliván with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mireia Oliván more than expected).

Fields of papers citing papers by Mireia Oliván

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mireia Oliván. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mireia Oliván. The network helps show where Mireia Oliván may publish in the future.

Co-authorship network of co-authors of Mireia Oliván

This figure shows the co-authorship network connecting the top 25 collaborators of Mireia Oliván. A scholar is included among the top collaborators of Mireia Oliván based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mireia Oliván. Mireia Oliván is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oliván, Mireia, Marta García, Marc Guiu, et al.. (2021). Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples. Cancers. 13(24). 6202–6202. 11 indexed citations
2.
Puig, Pere, Nadina Erill, Isaac Subirana, et al.. (2019). Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer. BMC Research Notes. 12(1). 68–68. 2 indexed citations
3.
Mengual, Lourdes & Mireia Oliván. (2017). Quantitative RNA Analysis from Urine Using Real Time PCR. Methods in molecular biology. 1655. 227–237. 4 indexed citations
4.
Moróte, Juan, A. Celma, Jacques Planas, et al.. (2016). Eficacia del índice de salud prostática para identificar cánceres de próstata agresivos. Una validación institucional. Actas Urológicas Españolas. 40(6). 378–385. 12 indexed citations
5.
Sequeiros, Tamara, Marina Rigau, Cristina Chiva, et al.. (2016). Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer. Oncotarget. 8(3). 4960–4976. 93 indexed citations
6.
Oliván, Mireia, Marina Rigau, Eva Colás, et al.. (2015). Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines. BioMed Research International. 2015. 1–11. 17 indexed citations
7.
Moróte, Juan, A. Celma, Jacques Planas, et al.. (2014). Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness. International Journal of Molecular Sciences. 15(8). 13615–13623. 25 indexed citations
8.
Rigau, Marina, Mireia Oliván, Marta García, et al.. (2013). The Present and Future of Prostate Cancer Urine Biomarkers. International Journal of Molecular Sciences. 14(6). 12620–12649. 56 indexed citations
9.
Moróte, Juan, A. Celma, Jacques Planas, et al.. (2013). Sedentarismo y sobrepeso como factores de riesgo en la detección del cáncer de próstata y su agresividad. Actas Urológicas Españolas. 38(4). 232–237. 15 indexed citations
10.
Sequeiros, Tamara, Marta García, Melania Montes, et al.. (2013). Molecular Markers for Prostate Cancer in Formalin-Fixed Paraffin-Embedded Tissues. BioMed Research International. 2013. 1–15. 16 indexed citations
11.
Batista, Miguél L., Mireia Oliván, Paulo Sérgio Martins de Alcântara, et al.. (2012). Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients. Cytokine. 61(2). 532–539. 87 indexed citations
12.
Oliveira, Cibely Cristine Fontes de, Sı́lvia Busquets, Míriam Toledo, et al.. (2012). Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: Altered energetic efficiency?. Biochimica et Biophysica Acta (BBA) - General Subjects. 1830(3). 2770–2778. 83 indexed citations
13.
Argilés, Josep M., Cibely Cristine Fontes de Oliveira, Gemma Fuster, et al.. (2010). Patterns of gene expression in muscle and fat in tumor‐bearing rats: Effects of CRF2R agonist on cachexia. Muscle & Nerve. 42(6). 936–949. 4 indexed citations
14.
Oliván, Mireia, et al.. (2010). Optimal management of cancer anorexia–cachexia syndrome. Cancer Management and Research. 2. 27–27. 59 indexed citations
15.
Oliván, Mireia, Sı́lvia Busquets, Maite Figueras, et al.. (2010). Nutraceutical inhibition of muscle proteolysis: A role of diallyl sulphide in the treatment of muscle wasting. Clinical Nutrition. 30(1). 33–37. 6 indexed citations
16.
Marín‐Corral, Judith, Sergi Pascual-Guàrdia, F. Javier Sánchez, et al.. (2009). Redox Balance and Carbonylated Proteins in Limb and Heart Muscles of Cachectic Rats. Antioxidants and Redox Signaling. 12(3). 365–380. 61 indexed citations
17.
Busquets, Sı́lvia, Gemma Fuster, Elisabet Ametller, et al.. (2007). Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models. Clinical Nutrition. 26(2). 239–244. 41 indexed citations
18.
Argilés, Josep M., Maite Figueras, Elisabet Ametller, et al.. (2007). Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells. Muscle & Nerve. 37(2). 190–195. 18 indexed citations
19.
Busquets, Sı́lvia, Elisabet Ametller, Gemma Fuster, et al.. (2006). Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model. Cancer Letters. 245(1-2). 144–148. 69 indexed citations
20.
Busquets, Sı́lvia, Cèlia Garcı́a-Martı́nez, Mireia Oliván, et al.. (2005). Overexpression of UCP3 in both murine and human myotubes is linked with the activation of proteolytic systems: A role in muscle wasting?. Biochimica et Biophysica Acta (BBA) - General Subjects. 1760(2). 253–258. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominick G. A. Burton Breakdown of academic impact, for papers by Reiko Matsui Breakdown of academic impact, for papers by Stefan K. Nilsson Breakdown of academic impact, for papers by Young‐Sil Yoon Breakdown of academic impact, for papers by Yi Pan Breakdown of academic impact, for papers by Yunbiao Lu Breakdown of academic impact, for papers by Krista P. Terracina Breakdown of academic impact, for papers by Gangarao Davuluri Breakdown of academic impact, for papers by Eric S. Muise Breakdown of academic impact, for papers by Naijin Zhang
Rankless by CCL
2026